Oxyphylla A: A New Breakthrough for the Treatment of Neurodegenerative Diseases

Oxyphylla A, is a natural, plant-based medicine for the treatment of PD and its novel mechanism of action includes activation of immunoproteasome. We have strong Proof-of-Principle evidence of protective and rescue effect on neurodegenerations and associated symptoms in animal studies.

We have various experimental data of neuroprotective effects on neurons in the brain; and improved behavioral and cognitive impairments in multiple PD mouse models. Pharmacokinetic and toxicity results have proved that Oxyphylla A has high level of safety, it has fast absorption, high bioavailability, and the ability to cross the blood-brain barrier. A total of six global patents granted (US, EU, Spain, China and Japan) covering treatment claim of new chemical entity, synthesis method, therapeutic use and application.